Encephalitis is an inflammation of the brain caused by viral, bacterial, autoimmune, or idiopathic factors, leading to altered consciousness, seizures, and neurological dysfunction. Prompt recognition and management are vital due to its potential severity and long-term cognitive consequences.

The Encephalitis session focuses on the immunopathology, clinical diagnosis, and therapeutic strategies for infectious and autoimmune encephalitis. Researchers discuss how immune responses, blood-brain-barrier breakdown, and cytokine storms trigger neuronal damage and neuroinflammation.

At the Encephalitis Conference, clinicians and scientists share recent findings on viral etiologies (such as HSV, Japanese encephalitis, and West Nile virus), antibody-mediated cases like anti-NMDA receptor encephalitis, and neuroimaging biomarkers guiding early diagnosis. Topics also cover emerging antiviral drugs, immunotherapies, and rehabilitation models for cognitive recovery.

This session provides an essential platform for neurologists, infectious-disease specialists, and immunologists. It emphasizes multidisciplinary collaboration for rapid intervention, neuroprotective care, and prevention through vaccination and public-health awareness.

Advancements in Neuroimmunopathology are revealing new insights into host–pathogen interactions, immune cross-reactivity, and mechanisms underlying post-infectious brain syndromes.